Assessing the prognosis of patients with chronic obstructive pulmonary disease

Journal of Organ Dysfunction

Volumn 3, Issue 4, 2007, Pages 250-254

  Doherty, Dennis E ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Chronic obstructive pulmonary disease; Dyspnea; Exacerbation; Exercise capacity; Prognosis; Pulmonary function tests

Indexed keywords

AIRWAY OBSTRUCTION; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE EXACERBATION; DYSPNEA; EXERCISE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERCAPNIA; HYPOXEMIA; INSPIRATORY CAPACITY; LUNG FUNCTION TEST; MEASUREMENT; MEDICAL RESEARCH COUNCIL SCALE; MORBIDITY; MORTALITY; NUTRITIONAL STATUS; OBSTRUCTED AIRFLOW DYSPNEA AND EXERCISE INDEX; PARAMETER; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RATING SCALE; REVIEW; SPIROMETRY; THORAX; TOTAL LUNG CAPACITY;

EID: 35848931480     PISSN: 17471060     EISSN: 17471079     Source Type: Journal    
DOI: 10.1080/17471060701214361     Document Type: Review

References (28)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. Respir Care 2002;47:1184-99.
2. Global Initiative on Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1256-76.
3. Celli BR, MacNee W: ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46. Updated 2006: accessible at www.goldcopd.org http://goldcopd.org/Guidelineitem.asp?11=2&12=1&intId=989
4. Doherty D. Detecting and managing COPD in the younger patient. J Respir Dis 2003;24:S14-28.
5. Doherty DE. Early detection and management of COPD. What you can do to reduce the impact of this disabling disease. Postgrad Med 2002;111:41-4, 49-50, 53 passim.
6. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Respir Care 2000;45:513-30.
7. Stedman's Medical Dictionary. Baltimore, MD: Lippincott, Williams & Wilkins; 2006.
8. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:14-20.
9. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. Br Med J 2000;320:1297-303.
10. Dewan NA, Rafique S, Kanwar B, Satpathy H, Ryschon K, Tillotson GS, et al. Acute exacerbation of COPD: factors associated with poor treatment outcome. Chest 2000;117:662-71.
11. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 1997;127:1072-9.
12. Friedman M, Serby CW, Menjoge SS, Wilson JD, Hilleman DE, Witek TJ Jr. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. Chest 1999;115:/635-41.
13. Burrows B. Airways obstructive diseases: pathogenetic mechanisms and natural histories of the disorders. Med Clin North Am 1990;74:547-59.
14. Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med 1990;11:555-69.
15. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:/591-7.
16. Doherty DE. Identification and assessment of chronic obstructive pulmonary disease in the elderly. J Am Med Dir Assoc 2003;4(5 Suppl):S116-20.
17. Fletcher CM, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Lancet 1959;i:257-66.
18. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121:1434-40.
19. Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu JM. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. Chest 1996;109:741-9.
20. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:961-6.
21. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989;139:1435-8.
22. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1791-7.
23. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: Data from the First National Health and Nutrition 2003. Thorax 58:388-93.
24. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005;128:2005-11.
25. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980;93:391-8.
26. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981;i:681-6.
27. Donaldson GC et al. Chest 2005;128:1995-2004.
28. Celli B, Cote CG, Marin JM, Casanova C, Montes M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.